Cobimetinib fumarate is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Peritoneal Cancer.

Cobimetinib fumarate is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Fallopian Tube Cancer.

Results can vary, but many users start to see significant changes within two to three months of consistent use, in ...

Women had a lower probability of receiving any disease-modifying treatment (DMT) and were even less likely to get ...

WHILE enjoying the last burst of summer sunshine, it’s natural that you might start to feel a bit glum. Believe it or not, ...

If approved, lenacapavir would be the first and only twice-yearly HIV prevention choice for people who need or want PrEP.

Zmyra's formula includes several active components. Caffeine anhydrous gives users an energy boost and may help burn fat.

AstraZeneca has completed clinical studies to transition Breztri, its inhaled treatment for COPD, to a next-generation ...